Index by author

March 01, 2010; Volume 77,Issue 3

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Bartholomew, John R.
1. You have access
  Interpreting the Jupiter trial: Statins can prevent VTE, but more study is needed
  Alejandro Perez, MD and John R. Bartholomew, MD
  Cleveland Clinic Journal of Medicine March 2010, 77 (3) 191-194; DOI: https://doi.org/10.3949/ccjm.77a.09077
  The incidence of venous thromboembolism in people taking rosuvastatin (Crestor) 20 mg/day was about half that in people taking placebo. This was a relatively healthy population, and the incidence in both groups was low.